Loading clinical trials...
Loading clinical trials...
The goal of this prospective observational cohort study is to validate previously developed Hepatocellular Carcinoma (HCC) risk prediction algorithms, the Liver Risk Computation (LIRIC) models, which ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborators
NCT06364371 · Predictive Cancer Model, Pathologic Complete Response
NCT06202404 · Metastasis, Predictive Cancer Model
NCT05929365 · Predictive Cancer Model
NCT05973331 · Pancreatic Adenocarcinoma, Predictive Cancer Model
NCT06339307 · Predictive Cancer Model, Gastric Cancer, and more
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions